JP2008538109A5 - - Google Patents

Download PDF

Info

Publication number
JP2008538109A5
JP2008538109A5 JP2008502895A JP2008502895A JP2008538109A5 JP 2008538109 A5 JP2008538109 A5 JP 2008538109A5 JP 2008502895 A JP2008502895 A JP 2008502895A JP 2008502895 A JP2008502895 A JP 2008502895A JP 2008538109 A5 JP2008538109 A5 JP 2008538109A5
Authority
JP
Japan
Prior art keywords
fluoro
alkyl
phenyl
methanesulfonylamino
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008502895A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008538109A (ja
JP5159604B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2006/000929 external-priority patent/WO2006101318A1/en
Publication of JP2008538109A publication Critical patent/JP2008538109A/ja
Publication of JP2008538109A5 publication Critical patent/JP2008538109A5/ja
Application granted granted Critical
Publication of JP5159604B2 publication Critical patent/JP5159604B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008502895A 2005-03-19 2006-03-15 バニロイド受容体拮抗薬としての新規な化合物、その異性体又はその薬剤学的に許容される塩、及びこれを含む医薬組成物 Expired - Fee Related JP5159604B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR20050022986 2005-03-19
KR10-2005-0022986 2005-03-19
US66326905P 2005-03-21 2005-03-21
US60/663,269 2005-03-21
PCT/KR2006/000929 WO2006101318A1 (en) 2005-03-19 2006-03-15 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same

Publications (3)

Publication Number Publication Date
JP2008538109A JP2008538109A (ja) 2008-10-09
JP2008538109A5 true JP2008538109A5 (cg-RX-API-DMAC7.html) 2009-04-09
JP5159604B2 JP5159604B2 (ja) 2013-03-06

Family

ID=37023953

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008502895A Expired - Fee Related JP5159604B2 (ja) 2005-03-19 2006-03-15 バニロイド受容体拮抗薬としての新規な化合物、その異性体又はその薬剤学的に許容される塩、及びこれを含む医薬組成物
JP2008502896A Expired - Fee Related JP5064374B2 (ja) 2005-03-19 2006-03-17 バニロイド受容体拮抗薬としての新規な化合物、その異性体またはその薬剤学的に許容される塩、及びこれを含む医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008502896A Expired - Fee Related JP5064374B2 (ja) 2005-03-19 2006-03-17 バニロイド受容体拮抗薬としての新規な化合物、その異性体またはその薬剤学的に許容される塩、及びこれを含む医薬組成物

Country Status (14)

Country Link
US (2) US7763657B2 (cg-RX-API-DMAC7.html)
EP (2) EP1861357B1 (cg-RX-API-DMAC7.html)
JP (2) JP5159604B2 (cg-RX-API-DMAC7.html)
KR (2) KR101304981B1 (cg-RX-API-DMAC7.html)
AR (2) AR056943A1 (cg-RX-API-DMAC7.html)
AU (2) AU2006225496A1 (cg-RX-API-DMAC7.html)
BR (2) BRPI0608714A2 (cg-RX-API-DMAC7.html)
CA (2) CA2601871A1 (cg-RX-API-DMAC7.html)
EA (2) EA200702020A1 (cg-RX-API-DMAC7.html)
IL (2) IL185891A0 (cg-RX-API-DMAC7.html)
MX (2) MX2007011466A (cg-RX-API-DMAC7.html)
NO (2) NO20075353L (cg-RX-API-DMAC7.html)
TW (2) TW200716523A (cg-RX-API-DMAC7.html)
WO (2) WO2006101318A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006225496A1 (en) * 2005-03-19 2006-09-28 Amorepacific Corporation Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
CA2658925C (en) 2006-07-27 2015-07-14 Amorepacific Corporation Novel sulfonylamino acrylamide derivatives, isomer thereof,or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
DE102007017884A1 (de) 2007-04-13 2008-10-16 Grünethal GmbH Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln
WO2009023025A1 (en) * 2007-08-13 2009-02-19 Board Of Trustees Of Southern Illinois University Methods for treatment and prevention of ototoxicity by sirna
WO2009096701A2 (en) 2008-01-28 2009-08-06 Amorepacific Corporation Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
EP2277861A4 (en) 2008-05-07 2012-05-02 Dainippon Sumitomo Pharma Co CYCLIC AMIN-1-CARBOXYLIC ACID EST DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREWITH
JP5438103B2 (ja) 2008-07-02 2014-03-12 アモーレパシフィック コーポレイション バニロイド受容体アンタゴニストとしての新規化合物、その異性体またはその薬学的に許容される塩、並びにそれを含む医薬組成物
ES2673301T3 (es) * 2010-11-03 2018-06-21 University Of Hawaii Métodos y composiciones para la prevención y el tratamiento de la hipertrofia cardíaca
AR085509A1 (es) 2011-03-09 2013-10-09 Bayer Cropscience Ag Indol- y bencimidazolcarboxamidas como insecticidas y acaricidas
US9012450B2 (en) 2011-12-28 2015-04-21 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
PL2797416T3 (pl) 2011-12-28 2017-12-29 Global Blood Therapeutics, Inc. Podstawione związki benzaldehydowe i sposoby ich zastosowania do zwiększania natlenienia tkanek
WO2014104272A1 (ja) * 2012-12-28 2014-07-03 日本臓器製薬株式会社 ケイ皮酸アミド誘導体
JP6426694B2 (ja) 2013-03-15 2018-11-21 グローバル ブラッド セラピューティクス インコーポレイテッド ヘモグロビンの修飾のための化合物及びその使用
EP2968299B1 (en) 2013-03-15 2021-01-20 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
BR112015021982B1 (pt) 2013-03-15 2022-12-13 Global Blood Therapeutics, Inc Compostos e seus usos para a modulação de hemoglobina
AP2016009261A0 (en) 2014-02-07 2016-06-30 Global Blood Therapeutics Inc Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
PL3383392T3 (pl) 2015-12-04 2025-11-17 Global Blood Therapeutics, Inc. Schematy dawkowania dla 2-hydroksy-6-((2-(1-izopropylo-1H-pirazol-5-ilo)pirydyn3-ylo)metoksy)benzaldehydu
EP3860975B1 (en) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6087254A (ja) * 1983-10-19 1985-05-16 Japan Carlit Co Ltd:The 新規尿素化合物及びそれを含有する除草剤
EP1154989B1 (en) * 1999-02-22 2005-12-14 Pacific Corporation Vanilloid analogues containing resiniferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof
NZ523882A (en) 2000-08-21 2004-11-26 Pacific Corp Novel thiourea derivatives and the pharmaceutical compositions containing the same
EP1311478B1 (en) * 2000-08-21 2006-06-07 Pacific Corporation Novel (thio)urea compounds and the pharmaceutical compositions containing the same
GB0105895D0 (en) * 2001-03-09 2001-04-25 Smithkline Beecham Plc Novel compounds
MXPA04005427A (es) 2001-12-10 2005-04-19 Amgen Inc Ligandos de receptor vainilloide y su uso en tratamientos.
EP1506167B1 (en) 2002-05-08 2007-08-29 Bayer HealthCare AG Hydroxy tetrahydro-naphthalenylurea derivatives
US7183411B2 (en) * 2002-07-12 2007-02-27 Janssen Pharmaceutica N.V. Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor
KR100707123B1 (ko) * 2003-07-02 2007-04-16 그뤼넨탈 게엠베하 바닐로이드 수용체의 길항제로서 강력한 진통효과를나타내는 4-(메틸설포닐아미노)페닐 동족체 및 이를함유하는 약학적 조성물
KR101042490B1 (ko) * 2004-07-15 2011-06-16 니뽄 다바코 산교 가부시키가이샤 축합 벤즈아미드 화합물 및 바닐로이드 수용체 1형(vr1)활성 저해제
ITMI20042042A1 (it) * 2004-10-26 2005-01-26 Pharmeste Srl Derivati solfonammidici antagonisti del recettore dei vanilloidi trpv1
EP1858865B1 (en) * 2005-03-10 2009-09-16 Pfizer Inc. Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
AU2006225496A1 (en) * 2005-03-19 2006-09-28 Amorepacific Corporation Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same

Similar Documents

Publication Publication Date Title
JP4850702B2 (ja) 優秀な鎮痛作用を示すバニロイドアンタゴニストとしての4−(メチルスルホニルアミノ)フェニルアナログおよびこれを含む医薬組成物
AU2007277519B2 (en) Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
RU2009119290A (ru) Производные гидантоина, используемые в качестве ингибиторов ммр
RU2011101951A (ru) Способ получения стимулятора апоптоза авт-263
JP2008505874A5 (cg-RX-API-DMAC7.html)
CA2667285A1 (en) New sulfonamide derivatives as bradykinin antagonists
CZ315196A3 (en) Sulfonamide derivatives and pharmaceutical composition containing thereof
CZ20013248A3 (cs) Nové sloučeniny a prostředky jako inhibitory proteázy
CA2577220A1 (fr) Derives de sulfonamides, leur preparation et leur application en therapeutique
US20030207939A1 (en) Novel 3-substituted urea derivatives and medicinal use thereof
RU2011134634A (ru) Индуцирующие апоптоз средства для лечения рака и иммунных и аутоиммунных заболеваний
JP2010522197A5 (cg-RX-API-DMAC7.html)
AU2020257561B2 (en) N-acyl-{4-((4-aryl-phenyl)sulfonylmethyl)piperidine} compounds and their therapeutic use
JP2008537547A5 (cg-RX-API-DMAC7.html)
CA2667481A1 (en) New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
RU2010107169A (ru) Фармацевтическая композиция, содержащая оптически активное соединение, обладающее активностью агониста рецептора тромбопоэтина, и промежуточное соединение для этого
JP2004503534A (ja) 15−リポキシゲナーゼの阻害剤としての1,2,4−三置換ベンゼン
JP5159604B2 (ja) バニロイド受容体拮抗薬としての新規な化合物、その異性体又はその薬剤学的に許容される塩、及びこれを含む医薬組成物
CN1124486A (zh) 含有杂环基团的脒衍生物及其制备和应用
JP2013525262A5 (cg-RX-API-DMAC7.html)
RU2008149936A (ru) (2r)-2-[(4-сульфонил)аминофенил]пропанамиды и содержащие их фармацевтические композиции
JP2013509376A5 (cg-RX-API-DMAC7.html)
JP2019501948A5 (cg-RX-API-DMAC7.html)
JP2006520367A5 (cg-RX-API-DMAC7.html)
RU2008144952A (ru) Производные аминометилпиридина, их получение и их применение в терапии